ABSTRACT
BACKGROUND: Eagle syndrome is an uncommon condition, characterized by alteration in the stylomastoid process and sometimes a complete calcification of the stylohyoid ligament. OBJECTIVE: To report the relevance of a timely diagnosis and treatment options. CASE REPORT: 53-year-old female, present symptoms, characterized by occipital headache and neck pain and dysphagia with one-year evolution, through studies Imaging and clinical, the diagnosis of eagle syndrome was obtained, which is treated by surgical transoral approach. CONCLUSIONS: Eagle syndrome consists of nonspecific clinical signs, so it is important to understand the diagnostic evaluation, and the variety of treatment options.
ANTECEDENTES: El síndrome de Eagle es una condición poco común caracterizada por una alteración en la apófisis estilomastoides o una calcificación completa del ligamento estilohioideo. OBJETIVO: Reportar la relevancia de un diagnóstico oportuno y las opciones de tratamiento. CASO CLÍNICO: Mujer de 53 años con síntomas de cefalea occipital, dolor cervical y disfagia con 1 año de evolución. Por medio de imagenología y la clínica se establece el diagnóstico de síndrome de Eagle, que fue tratado con un abordaje transoral. CONCLUSIONES: El síndrome de Eagle consta de signos clínicos inespecíficos, por lo que es importante comprender la evaluación diagnóstica y la variedad de opciones de tratamiento.
Subject(s)
Ossification, Heterotopic , Tomography, X-Ray Computed , Female , Humans , Middle Aged , Neck Pain/etiology , Ossification, Heterotopic/diagnosis , Ossification, Heterotopic/surgery , Temporal Bone/abnormalities , Temporal Bone/diagnostic imaging , Temporal Bone/surgeryABSTRACT
BACKGROUND: Mucormycosis is a rare, invasive disease associated with high mortality rates, produced by opportunistic pathogens related to the Mucorales order and characterised by a diverse range of clinical forms; acute rhino-orbital-cerebral and pulmonary symptoms are the most reported ones. OBJECTIVES: To report the experience of mucormycosis observed in a tertiary-care hospital in Mexico for 35 years. METHODS: This was a retrospective, descriptive and observational study on mucormycosis at a tertiary-care hospital in Mexico from January 1985 to December 2019. Demographic and clinical data and mycological and histopathological records were selected. RESULTS: Two hundred fourteen proven cases of mucormycosis for 35 years at a tertiary-care hospital in Mexico were included. Most of the cases were male patients with a median age of 45 years. The two most associated underlying diseases were diabetes mellitus (76.6%) and haematologic malignancy (15.4%). The three primary clinical forms were as follows: rhino-orbito-cerebral (75.9%), cutaneous (8.41%) and pulmonary (7.47%) mucormycosis. The most isolated agents were Rhizopus arrhizus (58.4%) and Lichtheimia corymbifera (12.3%). The overall therapeutic response was 58.5%, and the best response was observed with amphotericin B deoxycholate and surgical debridement. CONCLUSION: Mucormycosis is an emerging disease, and its incidence has increased at our hospital over the years. In this study, the rhino-cerebral clinical type was the most frequent in patients with uncontrolled diabetes; the main aetiological agent was R. arrhizus. Early diagnosis, control of the underlying disease and prompt management may increase the survival rate.
Subject(s)
Mucormycosis/epidemiology , Mucormycosis/mortality , Tertiary Care Centers/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Child , Child, Preschool , Deoxycholic Acid/therapeutic use , Drug Combinations , Female , Humans , Infant , Infant, Newborn , Male , Medical Records , Mexico/epidemiology , Middle Aged , Mucorales/genetics , Mucorales/pathogenicity , Mucormycosis/drug therapy , Retrospective Studies , Time Factors , Young AdultABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Carcinoma, Merkel Cell/diagnosis , Carcinoma, Merkel Cell/therapy , Ethmoid Sinus/pathology , Ethmoid Sinus , Paranasal Sinus Neoplasms/diagnosis , Paranasal Sinus Neoplasms/therapy , Immunohistochemistry/methods , ImmunohistochemistryABSTRACT
El síndrome de Immunodeficiencia Adquirida (SIDA) es de particular interés para el Otorrinolaringólogo y Cirujano de Cabeza y Cuello porque se ha estimado que entre el 40 por ciento y 80 por ciento de los pacientes con esta enfermedad presentan sintomatología o manifestaciones físicas en el área de la cabeza y el cuello. Por ello, revisamos 318 expedientes de pacientes con diagnóstico clínico, epidemiológico y serológico de SIDA vistos en el Hospital General de México entre mayo de 1993 y diciembre de 1994. Encontramos patología en cabeza y cuello en 169 (54.14 por ciento); de estos, 113 fueron del sexo masculino y 56 del sexo femenino. La cavidad oral presento patología en 87 de los pacientes (51.48 por ciento), orofaringe en 34 (20.12 por ciento), Nariz y senos paranasales en 26 (15.38 por ciento), piel de cabeza y cuello en 8 (4.73 por ciento), oído medio 7(4.14 por ciento), oído externo 4(2.37 por ciento, laringe 1 (0.59 por ciento) y un absceso lateral de cuello (0.59 por ciento)
Subject(s)
Adolescent , Adult , Middle Aged , Humans , Male , Female , AIDS-Related Opportunistic Infections/etiology , Otorhinolaryngologic Diseases/etiology , Mouth Diseases/etiology , Nose Diseases/etiology , Risk Factors , Acquired Immunodeficiency Syndrome/complicationsABSTRACT
Pneumocystis carinii es un patógeno oportunista frecuentemente involucrado en neumonitis en pacientes con síndrome de inmunodeficiencia adquirida(SIDA). En general, las manifestaciones estrapulmonares por P. carinii son raras y generalmente son asociadas a enfermedad sistemica grave, otros cuadros de inmunodeficiencia, enfermedades malignas o supresión inmune. Se presenta el caso de un paciente masculino portador del síndrome de inmunodeficiencia adquirida, con un cuadro de otitis media por Pneumocystis carinii, con otalgia severa, otorrea e hipoacusia conductiva. Se hace una revisión de la bibliografía sobre esta rara patología
